Applications will open: January 7, 2022
Letters of Intent (LOI) due: May 8, 2022
Full Proposals due: July 7, 2022
Funding Notification: September 2022
Letter of Intent (RE03) Due: May 8, 2022
Grant Application (RE03) Due: July 7, 2022
This opportunity is intended for emerging to mid-career oncology nurse researchers who have not previously received and completed at least one research study with a funding level of $50,000 as the study PI
If you have a demonstrated history of funding and have previously received and completed at least one research study with a funding level of $50,000 as the study PI, please use the application (RE33).
Purpose of Grant: To support rigorous scientific oncology nursing research. Research projects may include investigator-initiated research, pilot or feasibility studies, supplements to current funded projects, or developing a new aspect of a program of research. Funding preference is given to projects that involve nurses in the design and conduct of the research activity and that promote theoretically based oncology practice. Competitive applications will address a topic(s) in the ONS Research Agenda. See "Research Agenda of the Oncology Nursing Society: 2019-2022," published in the Oncology Nursing Forum, November 2019, Volume 46, No. 6.
The following three (3) key areas in need of oncology nursing research articulated in the ONS Research Agenda are:
• Symptom Science
◦ In Immunotherapy and Emerging Therapies in Precision Health
◦ In Precision Health and Biosignature
• Health Disparities
• Palliative and Psychosocial Oncology Care
Additional resources and updates related to the ONS Research Agenda are located here: “Update to the 2019-2022 ONS Research Agenda: Rapid Review to Address Structural Racism and Health Inequities,” published in the Oncology Nursing Forum, November 2021, Volume 48, No. 6; and, “The Oncology Nursing Society Rapid Review and Research Priorities for Cancer Care in the Context of Covid-19,” published in the Oncology Nursing Forum, March 2021, Volume 48, No. 2.
Eligibility: The principal investigator (individual primarily responsible for implementing the proposal and reporting to Oncology Nursing Foundation) must be a registered oncology nurse actively involved in some aspect of cancer patient care, education, or research and be PhD prepared (only one PI can appear on the grant). *At least one member of the research team must have received and completed research study funding of at least $100,000 in a PI capacity, thereby serving as a mentor for the project.
Research funding awarded under this grant program is in part generously supported by contributions to the Oncology Nursing Foundation from Bristol Myers Squibb, GlaxoSmithKline, and Merck & Co., Inc.
